Cures hiding in plain sight

Biologic drugs reimagined

Lumen unlocks the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. Our goal is to transform the way such drugs are developed, what they cost, and who has access to them.

About Us

Unrivaled speed, safety, and effectiveness

Our patented technology allows us to develop biologic drugs faster and with lower cost and risk than traditional methods.

More About Our Science

Neglected no more

Many highly prevalent diseases have proven impossible to treat with traditional drug-making tools, despite decades of research, so they’ve been essentially abandoned by drug makers. Lumen’s unique technology is ideally suited to finally address these indications.

C. difficile

$8B

problem for US hospitals annually

2.3%

of all US hospital costs annually

Covid-19

50%

of patients endure significant GI symptoms

25%

of patients reported only GI symptoms

IBD

3M

Americans currently living with IBD

ZERO

therapies for mild-to-moderate Crohn's

Metabolic Disease

No. 1

cause of death in the world

47M

Americans living with metabolic disease

Traveler's diarrhea

50M

travelers at risk annually

29%

affliction rate in US servicemembers

See our Pipeline

Strategic collaborations expand our reach

Collaboration has helped get us to where we are today, and it is key to addressing the full range of opportunities that exist for mass-scale biologics.